Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: a systematic review and meta-analysis.
Saved in:
| Title: | Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: a systematic review and meta-analysis. |
|---|---|
| Authors: | Shabil, Muhammed1,2, Khatib, Mahalaqua Nazli3, Ballal, Suhas4, Bansal, Pooja5, Tomar, Balvir S.6, Ashraf, Ayash7, Kumar, M. Ravi8, Sinha, Aashna9, Rawat, Pramod10,11, Gaidhane, Abhay M.12 abhay.psm@dmiher.edu.in, Sah, Sanjit13,14, Daniel, Afukonyo Shidoiku15 afukonyoshidoiku@tsuniversity.edu.ng, Yappalparvi, Ambanna16, Bushi, Ganesh17 |
| Source: | BMC Endocrine Disorders. 11/18/2024, Vol. 24 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14726823 |
|---|---|
| DOI: | 10.1186/s12902-024-01775-2 |
